Innovative Therapies

Our therapeutic pipeline is centered around highly personalized cancer vaccines designed to precisely stimulate the immune system against patient-specific cancer markers. Utilizing advanced genomic sequencing, AI-driven neoantigen prediction, and innovative delivery platforms, our therapies aim to significantly enhance the immune response and prevent cancer relapse. Initially targeting acute leukemia, we plan to expand our pipeline to include broader hematologic malignancies and selected solid tumor indications, thus addressing critical unmet medical needs across oncology and improving long-term patient outcomes.